By: Sarah Frier
Gameto Inc., a biotech company working on stem-cell therapies for women’s health, has raised $44 million in venture capital to help fund a clinical trial for its product that aims to improve the egg-freezing experience.


Sarah Frier is an Editor in charge of Big Tech coverage at Bloomberg. She focuses on themes such as artificial intelligence, machine learning, and their implications on the global economy, with particular interest in AI platforms, computer vision, generative AI, natural language processing, and robotics. Frier's work has been featured in prominent publications including The Washington Post, Fortune, and TIME.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .